2014 Q2 Form 10-Q Financial Statement
#000110465914037299 Filed on May 12, 2014
Income Statement
Concept | 2014 Q2 | 2014 Q1 | 2013 Q4 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $3.050M | $2.630M | $3.090M |
YoY Change | 13.81% | -12.91% | 8.04% |
% of Gross Profit | |||
Research & Development | $7.890M | $6.360M | $6.088M |
YoY Change | -22.18% | -33.85% | -39.43% |
% of Gross Profit | |||
Depreciation & Amortization | $40.00K | $33.00K | $50.00K |
YoY Change | -63.64% | -78.0% | -66.67% |
% of Gross Profit | |||
Operating Expenses | $10.95M | $8.989M | $9.179M |
YoY Change | -14.61% | -28.87% | -28.89% |
Operating Profit | -$8.989M | -$9.179M | |
YoY Change | -28.87% | -28.89% | |
Interest Expense | |||
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | $0.00 | $2.000K | $1.389M |
YoY Change | -100.0% | -96.36% | -4309.09% |
Pretax Income | -$10.94M | -$8.990M | -$7.790M |
YoY Change | -14.54% | -28.55% | -39.81% |
Income Tax | $0.00 | $0.00 | $0.00 |
% Of Pretax Income | |||
Net Earnings | -$10.94M | -$8.987M | -$7.790M |
YoY Change | -14.53% | -28.57% | -27.3% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$1.451M | -$1.352M | -$1.301M |
COMMON SHARES | |||
Basic Shares Outstanding | 75.16M shares | 75.16M shares | 63.19M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2014 Q2 | 2014 Q1 | 2013 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $17.30M | $27.80M | $14.70M |
YoY Change | -45.25% | -34.12% | -73.8% |
Cash & Equivalents | $11.20M | $22.43M | $14.53M |
Short-Term Investments | $6.100M | $5.300M | $200.0K |
Other Short-Term Assets | $1.200M | $1.300M | $400.0K |
YoY Change | 20.0% | -7.14% | -42.86% |
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $18.50M | $29.06M | $15.17M |
YoY Change | -43.25% | -33.35% | -73.3% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $100.0K | $86.00K | $112.0K |
YoY Change | -66.67% | -77.89% | -77.91% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $600.0K | $738.0K | $434.0K |
YoY Change | -33.33% | -33.03% | -54.74% |
TOTAL ASSETS | |||
Total Short-Term Assets | $18.50M | $29.06M | $15.17M |
Total Long-Term Assets | $600.0K | $738.0K | $434.0K |
Total Assets | $19.10M | $29.79M | $15.61M |
YoY Change | -42.99% | -33.35% | -72.99% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $1.000M | $619.0K | $808.0K |
YoY Change | -44.44% | -43.73% | -52.67% |
Accrued Expenses | $2.700M | $3.900M | $3.800M |
YoY Change | -58.46% | -44.29% | -51.28% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $3.700M | $4.513M | $4.567M |
YoY Change | -55.42% | -44.62% | -51.9% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $100.0K | $195.0K | $354.0K |
YoY Change | -75.0% | -60.04% | -38.75% |
Total Long-Term Liabilities | $100.0K | $195.0K | $354.0K |
YoY Change | -75.0% | -60.04% | -38.75% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $3.700M | $4.513M | $4.567M |
Total Long-Term Liabilities | $100.0K | $195.0K | $354.0K |
Total Liabilities | $3.900M | $4.708M | $4.921M |
YoY Change | -55.17% | -45.49% | -51.15% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$464.3M | -$455.4M | |
YoY Change | 9.04% | 10.19% | |
Common Stock | $489.4M | $466.0M | |
YoY Change | 5.96% | 1.11% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $15.30M | $25.09M | $10.68M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $19.10M | $29.79M | $15.61M |
YoY Change | -42.99% | -33.35% | -72.99% |
Cashflow Statement
Concept | 2014 Q2 | 2014 Q1 | 2013 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$10.94M | -$8.987M | -$7.790M |
YoY Change | -14.53% | -28.57% | -27.3% |
Depreciation, Depletion And Amortization | $40.00K | $33.00K | $50.00K |
YoY Change | -63.64% | -78.0% | -66.67% |
Cash From Operating Activities | -$9.890M | -$8.087M | -$7.650M |
YoY Change | -12.94% | -41.92% | -24.03% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $0.00 | $4.000K | $0.00 |
YoY Change | -86.21% | -100.0% | |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$730.0K | -$5.150M | $2.900M |
YoY Change | -127.04% | -362.76% | -85.06% |
Cash From Investing Activities | -$730.0K | -$5.149M | $2.900M |
YoY Change | -127.14% | -366.65% | -85.04% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -620.0K | $21.14M | 0.000 |
YoY Change | -178.48% | 25065.48% | -100.0% |
NET CHANGE | |||
Cash From Operating Activities | -9.890M | -$8.087M | -7.650M |
Cash From Investing Activities | -730.0K | -$5.149M | 2.900M |
Cash From Financing Activities | -620.0K | $21.14M | 0.000 |
Net Change In Cash | -11.24M | $7.903M | -4.750M |
YoY Change | 42.64% | -166.37% | -151.08% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$9.890M | -$8.087M | -$7.650M |
Capital Expenditures | $0.00 | $4.000K | $0.00 |
Free Cash Flow | -$9.890M | -$8.091M | -$7.650M |
YoY Change | -12.94% | -42.01% | -23.96% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2013Q4 | gtxi |
Accrual For Product Returns Included In Other Long Term Liabilities
AccrualForProductReturnsIncludedInOtherLongTermLiabilities
|
332000 | USD |
CY2014Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
10382571 | shares |
CY2014Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
29793000 | USD |
CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
15605000 | USD |
CY2013Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2014Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Use of Estimates</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 0.2in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The preparation of condensed financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed financial statements, and the reported amounts of revenues and expenses during the reporting period.  Actual amounts and results could differ from those estimates.</font></p> <p style="TEXT-INDENT: 0.2in; MARGIN: 0in 0in 0pt;"> </p> </div> | |
CY2013Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
6680423 | shares |
CY2014Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
75000 | USD |
CY2013Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
63000 | USD |
CY2014Q1 | us-gaap |
Revenue Recognition Sales Of Goods
RevenueRecognitionSalesOfGoods
|
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">FARESTON</font></i></b><font style="POSITION: relative; FONT-SIZE: 6.5pt; TOP: -3pt;" size="1">®</font><b><i><font style="FONT-STYLE: italic; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2"> Revenue Recognition</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 13.7pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Although the Company sold its rights and certain assets related to FARESTON</font><font style="POSITION: relative; FONT-SIZE: 6.5pt; TOP: -3pt;" size="1">®</font><font style="FONT-SIZE: 10pt;" size="2"> effective September 30, 2012, the Company retained the liability for future product returns relating to sales of FARESTON</font><font style="POSITION: relative; FONT-SIZE: 6.5pt; TOP: -3pt;" size="1">®</font><font style="FONT-SIZE: 10pt;" size="2"> made by the Company prior to September 30, 2012.  Therefore, the Company estimates an accrual for product returns based on factors which include historical product returns and estimated product in the distribution channel which is expected to exceed its expiration date.  At March 31, 2014 and December 31, 2013, the Company’s accrual for product returns, was $454 and $918, respectively.  Of these amounts, $189 and $332 have been included in “Other long-term liabilities” in the condensed balance sheet at March 31, 2014 and December 31, 2013, respectively, and represents the portion of the Company’s product returns accrual estimated to be payable after one year.  The accrual for product returns decreased during the current period due to the closure of the return period for a portion of the previously sold inventory.</font></p> <p style="TEXT-INDENT: 13.7pt; MARGIN: 0in 0in 0pt;"> </p> </div> | |
CY2014Q1 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
CY2014Q1 | gtxi |
Accrual For Product Returns
AccrualForProductReturns
|
454000 | USD |
CY2013Q4 | gtxi |
Accrual For Product Returns
AccrualForProductReturns
|
918000 | USD |
CY2014Q1 | gtxi |
Accrual For Product Returns Included In Other Long Term Liabilities
AccrualForProductReturnsIncludedInOtherLongTermLiabilities
|
189000 | USD |
CY2014Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2247000 | USD |
CY2013Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
856000 | USD |
CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.879 | pure |
CY2013Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.744 | pure |
CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.023 | pure |
CY2013Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.011 | pure |
CY2014Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y6M | |
CY2013Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y6M | |
CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
6215809 | shares |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
6445342 | shares |
CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
2000 | shares |
CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
231533 | shares |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
6.58 | |
CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
6.38 | |
CY2014Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
1.74 | |
CY2014Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
GTX INC /DE/ | |
CY2014Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001260990 | |
CY2014Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2014Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2014-03-31 | |
CY2014Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2014Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2014Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2014Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Accelerated Filer | |
CY2014Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
75161437 | shares |
CY2014Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2014 | |
CY2014Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2014Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
22432000 | USD |
CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
14529000 | USD |
CY2014Q1 | us-gaap |
Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
|
5345000 | USD |
CY2013Q4 | us-gaap |
Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
|
200000 | USD |
CY2014Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1278000 | USD |
CY2013Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
442000 | USD |
CY2014Q1 | us-gaap |
Assets Current
AssetsCurrent
|
29055000 | USD |
CY2013Q4 | us-gaap |
Assets Current
AssetsCurrent
|
15171000 | USD |
CY2014Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
619000 | USD |
CY2013Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
808000 | USD |
CY2014Q1 | gtxi |
Accrued And Other Current Liabilities
AccruedAndOtherCurrentLiabilities
|
3894000 | USD |
CY2013Q4 | gtxi |
Accrued And Other Current Liabilities
AccruedAndOtherCurrentLiabilities
|
3759000 | USD |
CY2014Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
86000 | USD |
CY2013Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
112000 | USD |
CY2014Q1 | gtxi |
Intangible And Other Assets
IntangibleAndOtherAssets
|
652000 | USD |
CY2013Q4 | gtxi |
Intangible And Other Assets
IntangibleAndOtherAssets
|
322000 | USD |
CY2014Q1 | us-gaap |
Assets
Assets
|
29793000 | USD |
CY2013Q4 | us-gaap |
Assets
Assets
|
15605000 | USD |
CY2014Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4513000 | USD |
CY2013Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4567000 | USD |
CY2014Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
195000 | USD |
CY2013Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
354000 | USD |
CY2014Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
489357000 | USD |
CY2013Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
465981000 | USD |
CY2014Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-464347000 | USD |
CY2013Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-455360000 | USD |
CY2014Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
25085000 | USD |
CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
10684000 | USD |
CY2014Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2014Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2013Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2014Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
120000000 | shares |
CY2013Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
120000000 | shares |
CY2014Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
75161437 | shares |
CY2013Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
63185389 | shares |
CY2014Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
75161437 | shares |
CY2013Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
63185389 | shares |
CY2014Q1 | us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
6360000 | USD |
CY2013Q1 | us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
9614000 | USD |
CY2014Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2629000 | USD |
CY2013Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
3023000 | USD |
CY2014Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
8989000 | USD |
CY2013Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
12637000 | USD |
CY2014Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-8989000 | USD |
CY2013Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-12637000 | USD |
CY2014Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
2000 | USD |
CY2013Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
55000 | USD |
CY2014Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8987000 | USD |
CY2013Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-12582000 | USD |
CY2014Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.14 | |
CY2013Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.20 | |
CY2014Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
66512069 | shares |
CY2013Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
62864140 | shares |
CY2014Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
33000 | USD |
CY2013Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
150000 | USD |
CY2014Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2215000 | USD |
CY2013Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
814000 | USD |
CY2014Q1 | us-gaap |
Deferred Compensation Arrangement With Individual Compensation Expense
DeferredCompensationArrangementWithIndividualCompensationExpense
|
32000 | USD |
CY2013Q1 | us-gaap |
Deferred Compensation Arrangement With Individual Compensation Expense
DeferredCompensationArrangementWithIndividualCompensationExpense
|
42000 | USD |
CY2014Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1169000 | USD |
CY2013Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
913000 | USD |
CY2014Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-189000 | USD |
CY2013Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-607000 | USD |
CY2014Q1 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-22000 | USD |
CY2013Q1 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-827000 | USD |
CY2014Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
4000 | USD |
CY2013Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
29000 | USD |
CY2014Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-8087000 | USD |
CY2013Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-13923000 | USD |
CY2014Q1 | us-gaap |
Payments For Proceeds From Heldtomaturity Securities Shortterm
PaymentsForProceedsFromHeldtomaturitySecuritiesShortterm
|
5145000 | USD |
CY2013Q1 | us-gaap |
Payments For Proceeds From Heldtomaturity Securities Shortterm
PaymentsForProceedsFromHeldtomaturitySecuritiesShortterm
|
1225000 | USD |
CY2013Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
|
3185000 | USD |
CY2014Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-5149000 | USD |
CY2013Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
1931000 | USD |
CY2014Q1 | us-gaap |
Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
|
2000 | USD |
CY2013Q1 | us-gaap |
Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
|
2000 | USD |
CY2013Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
86000 | USD |
CY2014Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
21139000 | USD |
CY2013Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
84000 | USD |
CY2013Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
36136000 | USD |
CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
48044000 | USD |
CY2014Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
7903000 | USD |
CY2013Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-11908000 | USD |
CY2014Q1 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
21141000 | USD |